Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Andrology

  Free Subscription


29.05.2017

4 BJU Int
1 Hum Reprod
2 J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BJU Int

  1. STONE BV, Shoag J, Halpern JA, Mittal S, et al
    Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men.
    BJU Int. 2017;119:298-304.
    PubMed     Text format     Abstract available

  2. TORBRAND C, Wigertz A, Drevin L, Folkvaljon Y, et al
    Socioeconomic factors and penile cancer risk and mortality; a population-based study.
    BJU Int. 2017;119:254-260.
    PubMed     Text format     Abstract available

  3. WALLIS CJD, Saskin R, Narod SA, Law C, et al
    Estimating the effect of immortal-time bias in urologic research: a case example of testosterone-replacement therapy.
    BJU Int. 2017 May 26. doi: 10.1111/bju.13918.
    PubMed     Text format     Abstract available


  4. GreenLight XPS for treating benign prostatic hyperplasia: (c) NICE (2016) GreenLight XPS for treating benign prostatic hyperplasia.
    BJU Int. 2017;119:823-830.
    PubMed     Text format    


    Hum Reprod

  5. ALIPOUR H, Van Der Horst G, Christiansen OB, Dardmeh F, et al
    Improved sperm kinematics in semen samples collected after 2 h versus 4-7 days of ejaculation abstinence.
    Hum Reprod. 2017 May 22:1-9. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Urol

  6. KAPLAN SA
    Prostate Arterial Embolization is a Viable Option for Treating Symptoms of Benign Prostatic Hyperplasia: Con.
    J Urol. 2017 May 20. pii: S0022-5347(17)46147-7. doi: 10.1016/j.juro.2017.
    PubMed     Text format    

  7. YOUNG S, Golzarian J
    Prostate Arterial Embolization is a Viable Option for Treating Symptoms of Benign Prostatic Hyperplasia: Pro.
    J Urol. 2017 May 20. pii: S0022-5347(17)46151-9. doi: 10.1016/j.juro.2017.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Andrology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: